{"component": "definition", "props": {"groups": [{"size": 13, "snippet": "means any entity engaged by Customer for the Processing of Personal Data.", "samples": [{"hash": "jr5hDBiVLzy", "uri": "/contracts/jr5hDBiVLzy#third-party-partner", "label": "Data Processing Agreement", "score": 36.4182173196, "published": true}, {"hash": "jZ4WOT0WRKE", "uri": "/contracts/jZ4WOT0WRKE#third-party-partner", "label": "Data Processing Agreement", "score": 33.6680183411, "published": true}, {"hash": "1yReAeUVInz", "uri": "/contracts/1yReAeUVInz#third-party-partner", "label": "Data Processing Addendum", "score": 32.9157600403, "published": true}], "snippet_links": [{"key": "customer-for", "type": "clause", "offset": [28, 40]}, {"key": "the-processing-of-personal-data", "type": "clause", "offset": [41, 72]}], "hash": "a01a397979eaa2f5a7bebb7dd0448159", "id": 1}, {"size": 12, "snippet": "means a Third Party that has entered into a Partnering Agreement.", "samples": [{"hash": "eBrPTQpFg8M", "uri": "/contracts/eBrPTQpFg8M#third-party-partner", "label": "Option and License Agreement (Furiex Pharmaceuticals, Inc.)", "score": 21.3942508698, "published": true}, {"hash": "jFZUTcPFKEw", "uri": "/contracts/jFZUTcPFKEw#third-party-partner", "label": "Option and License Agreement (Furiex Pharmaceuticals, Inc.)", "score": 21.3641338348, "published": true}, {"hash": "3re0f4a7KDY", "uri": "/contracts/3re0f4a7KDY#third-party-partner", "label": "Option and License Agreement (Furiex Pharmaceuticals, Inc.)", "score": 21.1478443146, "published": true}], "snippet_links": [{"key": "a-third-party", "type": "clause", "offset": [6, 19]}, {"key": "entered-into", "type": "clause", "offset": [29, 41]}, {"key": "partnering-agreement", "type": "clause", "offset": [44, 64]}], "hash": "df9960ff195ae2b93046d36e7264bcc9", "id": 2}, {"size": 5, "snippet": "means any Third Party that is a partner, collaborator or licensee (including a Third Party that has been granted any options to any license) of Ablynx hereto under a partnership, collaboration or license arrangement (including any option arrangement) that is directed towards Discovery, Research and/or Developments of Nanobodies (and products comprising the same) by said Third Party (either on its own, in collaboration with Ablynx or under an arrangement of co-ownership with Ablynx).", "samples": [{"hash": "8fzDRyW9JCs", "uri": "/contracts/8fzDRyW9JCs#third-party-partner", "label": "Research Collaboration and Exclusive License Agreement (Ablynx NV)", "score": 28.8001365662, "published": true}, {"hash": "1QM5uxnpjDI", "uri": "/contracts/1QM5uxnpjDI#third-party-partner", "label": "Research Collaboration and Exclusive License Agreement (Ablynx NV)", "score": 28.8001365662, "published": true}, {"hash": "iuiYEuDjYWG", "uri": "/contracts/iuiYEuDjYWG#third-party-partner", "label": "Research Collaboration and Exclusive License Agreement (Ablynx NV)", "score": 28.7919235229, "published": true}], "snippet_links": [{"key": "a-third-party", "type": "clause", "offset": [77, 90]}], "hash": "e61965c1566a526469a75e23d69199f7", "id": 3}, {"size": 5, "snippet": "means any entity that contracts with LICENSEE for the purpose of LICENSEE developing for and delivering to such entity any deliverable (each, a \u201cDeliverable\u201d) that is either [\u2026***\u2026].", "samples": [{"hash": "8rn1ibFWEVx", "uri": "/contracts/8rn1ibFWEVx#third-party-partner", "label": "License Agreement", "score": 30.7724018097, "published": true}, {"hash": "j1BoFzPYVt1", "uri": "/contracts/j1BoFzPYVt1#third-party-partner", "label": "License Agreement (Genomatica Inc)", "score": 21.1163578033, "published": true}, {"hash": "9HBUc5SQBNO", "uri": "/contracts/9HBUc5SQBNO#third-party-partner", "label": "License Agreement (Genomatica Inc)", "score": 20.837097168, "published": true}], "snippet_links": [{"key": "contracts-with", "type": "clause", "offset": [22, 36]}, {"key": "of-licensee", "type": "clause", "offset": [62, 73]}], "hash": "2a781ddbb9bc73d4d00a2d293b30ab92", "id": 4}, {"size": 5, "snippet": "has the definition set forth in Section 3.1(b).", "samples": [{"hash": "cLZgnw9EUmU", "uri": "/contracts/cLZgnw9EUmU#third-party-partner", "label": "Collaboration and License Agreement (Clovis Oncology, Inc.)", "score": 24.8822727203, "published": true}, {"hash": "3oq3Hrj9bKe", "uri": "/contracts/3oq3Hrj9bKe#third-party-partner", "label": "Collaboration and License Agreement (XOMA Corp)", "score": 23.1984939575, "published": true}, {"hash": "8zbGDqsU4rb", "uri": "/contracts/8zbGDqsU4rb#third-party-partner", "label": "Collaboration and License Agreement (Xoma LTD /De/)", "score": 22.1854896545, "published": true}], "snippet_links": [{"key": "the-definition", "type": "definition", "offset": [4, 18]}], "hash": "096696ca3bb97b3c1001c9898eab25c8", "id": 5}, {"size": 4, "snippet": "has the meaning set forth in Section 4.7(e).", "samples": [{"hash": "130R4qVyoLg", "uri": "/contracts/130R4qVyoLg#third-party-partner", "label": "License Agreement (BioLineRx Ltd.)", "score": 22.4948673248, "published": true}, {"hash": "b8jf8DJe4P9", "uri": "/contracts/b8jf8DJe4P9#third-party-partner", "label": "License Agreement (Cypress Bioscience Inc)", "score": 21.6023273468, "published": true}], "snippet_links": [], "hash": "778de805325618dd96c7bbf1967c09d0", "id": 6}, {"size": 3, "snippet": "means one or more Third Party licensees or joint venturers, to whom Aquinox grants rights for development and commercialization of the Product in the Aquinox Territory.", "samples": [{"hash": "ld7M1h5oNEU", "uri": "/contracts/ld7M1h5oNEU#third-party-partner", "label": "Exclusive License and Collaboration Agreement (Aquinox Pharmaceuticals, Inc)", "score": 29.5995883942, "published": true}, {"hash": "cfomuMeqihc", "uri": "http://investor.aqxpharma.com/static-files/5cd6650b-8162-4fd0-915f-0fcb29b3d74e", "label": "investor.aqxpharma.com", "score": 10.1704311371, "published": false}, {"hash": "1Jh6qRbXrFP", "uri": "https://investor.neoleukin.com/static-files/b09b1ea2-8a64-4435-8b0c-c56158e81894", "label": "investor.neoleukin.com", "score": 9.9952087402, "published": false}], "snippet_links": [{"key": "third-party-licensees", "type": "clause", "offset": [18, 39]}, {"key": "joint-venturers", "type": "definition", "offset": [43, 58]}, {"key": "commercialization-of-the-product", "type": "clause", "offset": [110, 142]}], "hash": "2bdbc69ef2bea2ed890513f47ea0fca9", "id": 7}, {"size": 3, "snippet": "means, for an Existing Collaboration Agreement, the Third Party that is the counterparty (to NGM) in such agreement.", "samples": [{"hash": "dzwaWJjg9Mz", "uri": "/contracts/dzwaWJjg9Mz#third-party-partner", "label": "Research Collaboration, Product Development and License Agreement (NGM Biopharmaceuticals Inc)", "score": 32.5920600891, "published": true}, {"hash": "d6jH4hVVcQ6", "uri": "/contracts/d6jH4hVVcQ6#third-party-partner", "label": "Research Collaboration, Product Development and License Agreement (NGM Biopharmaceuticals Inc)", "score": 29.7392196655, "published": true}, {"hash": "2MHptnfRNAL", "uri": "/contracts/2MHptnfRNAL#third-party-partner", "label": "Research Collaboration, Product Development and License Agreement (NGM Biopharmaceuticals Inc)", "score": 29.6050643921, "published": true}], "snippet_links": [{"key": "existing-collaboration-agreement", "type": "definition", "offset": [14, 46]}, {"key": "the-third-party", "type": "definition", "offset": [48, 63]}, {"key": "the-counterparty", "type": "clause", "offset": [72, 88]}], "hash": "79192cea93090558ac402d1117020724", "id": 8}, {"size": 2, "snippet": "means any Third Party that sells bulk or packaged gas to any Person.", "samples": [{"hash": "lgg4U04gTf9", "uri": "/contracts/lgg4U04gTf9#third-party-partner", "label": "Equity Purchase Agreement (Airgas East Inc)", "score": 21.0, "published": true}, {"hash": "bnnEmIuQGrb", "uri": "/contracts/bnnEmIuQGrb#third-party-partner", "label": "Equity Purchase Agreement (Nitrous Oxide Corp)", "score": 21.0, "published": true}], "snippet_links": [{"key": "third-party", "type": "clause", "offset": [10, 21]}, {"key": "any-person", "type": "clause", "offset": [57, 67]}], "hash": "c7115f1acb742414d043f720c93208f7", "id": 9}, {"size": 2, "snippet": "means \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 Medicament SAS (\u201cPFM\u201d) and any other Third Party to which Array grants a license or sublicense, as applicable, under the Array Patents and Array Know How to market and sell Product(s) outside the Ono Territory, either with or without accompanying rights to Develop and/or Manufacture such Product(s).", "samples": [{"hash": "lflTnYi9Z6N", "uri": "/contracts/lflTnYi9Z6N#third-party-partner", "label": "License, Development and Commercialization Agreement (Array Biopharma Inc)", "score": 28.6851463318, "published": true}, {"hash": "lglZbfhjiBl", "uri": "/contracts/lglZbfhjiBl#third-party-partner", "label": "License, Development and Commercialization Agreement (Array Biopharma Inc)", "score": 28.6084880829, "published": true}], "snippet_links": [{"key": "other-third-party", "type": "definition", "offset": [50, 67]}, {"key": "array-patents", "type": "definition", "offset": [140, 153]}, {"key": "ono-territory", "type": "definition", "offset": [215, 228]}, {"key": "rights-to-develop", "type": "clause", "offset": [266, 283]}], "hash": "289513fed41ffea286305b1ce6dc7a7a", "id": 10}], "next_curs": "CmASWmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIcdGhpcmQtcGFydHktcGFydG5lciMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"size": 77, "snippet": "means any entity engaged by Customer for the Processing of Personal Data.", "title": "Third Party Partner", "id": "third-party-partner", "examples": ["We cannot guarantee that the request will be met and any failure to do so will not be a breach of these Terms or the <strong>Third Party Partner</strong>.", "Any registration required by a <strong>Third Party Partner</strong> is not governed by this \u2587\u2587\u2587\u2587 and you should refer to the relevant <strong>Third Party Partner</strong>\u2019s website for their policies.", "Notwithstanding any sublicense by PII of its rights under Section 3.01 or elsewhere in this Agreement, PII shall remain the primary obligor for the completion of the Development of the Compound and Licensed Products, the commercialization of the Licensed Products and all other obligations, including payment obligations, under this Agreement and shall be responsible for any breach or failure to comply by any sublicensee or <strong>Third Party Partner</strong> of any of the obligations of PII provided in this Agreement.", "PII shall have responsibility for, and shall exercise Diligent Efforts in, obtaining necessary Regulatory Approvals, and PII or its Affiliates, sublicensees or <strong>Third Party Partner</strong>, shall hold legal title of any [*] for the Licensed Product(s) and shall have responsibility for all the Development, manufacture and marketing activities pursuant to and in support of such applications.", "If RBX or any of RBX\u2019s Affiliates or PII or any of PII\u2019s Affiliates, sublicensees or <strong>Third Party Partner</strong> shall be sued by, threatened to be sued by or receives a claim from, a Third Party for infringement of a Third Party Patent because of the making, using, selling, offering for sale or importing, or having made, used, sold, offered for sale [*] Confidential treatment requested; certain information omitted and filed separately with the SEC.", "Publisher\u2019s Apps may provide access or links to <strong>Third Party Partner</strong> websites or resources.", "Both Parties, and any Third Party vendors or any sublicensee or <strong>Third Party Partner</strong> of PII, shall be excused from the performance of their obligations under this Agreement to the extent that such performance is prevented, in whole or in part, by Force Majeure events and the nonperforming Party promptly provides notice of the prevention to the other Party.", "PII shall keep and shall require any Affiliates, sublicensees and <strong>Third Party Partner</strong> selling any Licensed Product to keep proper records and books of account, in accordance with GAAP, showing the Net Sales of each Licensed Product upon which the royalty payments and Sales Milestone Payments of PII are based, and all other information necessary for the accurate determination of royalty payments to be made hereunder.", "The <strong>Third Party Partner</strong> may, but shall not be obligated to, purchase or license, as applicable, the Licensor Ancillary Improvement subject to the Notice of Intended Transfer or License on the offered terms and conditions or those terms and conditions negotiated by the Licensor and the Licensee.", "If rights in the Licensee Ancillary Improvement have been acquired by the <strong>Third Party Partner</strong>, then such rights shall not be available for purchase or license by Licensor pursuant to Section 6.2(e)."], "related": [["third-party-owner", "Third Party Owner", "Third Party Owner"], ["co-licensed-partner", "Co-licensed partner", "Co-licensed partner"], ["third-party-payer", "Third-party payer", "Third-party payer"], ["third-party-product", "Third Party Product", "Third Party Product"], ["nonaffiliated-third-party", "Nonaffiliated third party", "Nonaffiliated third party"]], "related_snippets": [], "updated": "2025-07-17T06:21:00+00:00"}, "json": true, "cursor": ""}}